Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1242-1253

  Hussain, Afzal ^a   Haque, Md Wasimul ^a   Singh, Sandeep Kumar ^a   Ahmed, Farhan Jalees ^b  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

5 Fluorouracil; elastic liposome; experimental design; permeation flux; topical delivery

Indexed keywords

FLUOROURACIL; LAUROCAPRAM; LAURYL ALCOHOL; LIPOSOME; PENETRATION ENHANCING AGENT; POLYSORBATE 80; PROPYLENE GLYCOL; SORBITAN OLEATE; SORBITAN STEARATE; GEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; DRUG SYNTHESIS; EXPERIMENTAL RABBIT; GEL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN IRRITATION; TRANSDERMAL DRUG DELIVERY SYSTEM; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; ELASTICITY; KERATOSIS; MEDICINAL CHEMISTRY; METABOLISM; RABBIT; SKIN NEOPLASMS; VISCOSITY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; ELASTICITY; FLUOROURACIL; GELS; KERATOSIS; LIPOSOMES; PROPYLENE GLYCOL; RABBITS; RATS; SKIN NEOPLASMS; VISCOSITY;

EID: 84951282640     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1124473     Document Type: Article

References (29)

1. P.P.Bhatt, J.H.Rytting, E.M.Topp (1991). Influence of Azone® and lauryl alcohol on the transport of acetaminophen and ibuprofen through shed snake skin. Int J Pharm 72:219–26
2. M.D.Contreras, R.Sanchez (2002). Application of a factorial design to the study of the flow behavior, spreadability and transparency of a Carbopol ETD 2020 gel. Part II. Int J Pharm 234:149–57
3. D.Cosco, D.Paolino, J.Maiuolo,. (2015). Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery. Int J Pharm 489:1–10
4. A.Dahan, A.Hoffman (2008). Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release 129:1–10
5. G.Darwhekar, D.K.Jain, A.Choudhary (2012). Elastic liposomes for delivery of neomycin sulphate in deep skin infection. Asian J Pharm Sci 7:230–40
6. R.B.Diasio, B.E.Harris (1989). Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 16:215–37
7. J.Draize, G.Woodard, H.Calvery (1944). Methods for the study of irritation and toxicity of substance applied to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–90
8. G.M.El Maghraby, A.C.Williams, B.W.Barry (2001). Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol 53:1069–77
9. R.J.Fraile, L.H.Baker, T.R.Buroker,. (1980). Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 40:2223–8
10. M.Grit, W.J.Underberg, D.J.Crommelin (1993). Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J Pharm Sci 82:362–6
11. A.Hussain, A.Samad, I.Nazish, F.J.Ahmed,. (2013). Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 40:527–41
12. A.Hussain, A.Samad, M.Ramzan,. (2014a). Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Drug Deliv 14:1–15
13. A.Hussain, A.Samad, S.K.Singh,. (2014b). Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv 21:1–16
14. S.K.Jain, Y.Gupta, A.Jain, K.Rai (2008). Enhanced transdermal delivery of acyclovir sodium via elastic liposome. Drug Deliv 15:141–7
15. N.Kaiser, A.Kimpfler, U.Massing,. (2003). 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties. Int J Pharm 256:123–31
16. S.Khurana, N.K.Jain, P.M.Bedi (2013). Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci 92:383–92
17. L.F.Lai, H.X.Guo (2011). Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int J Pharm 404:317–23
18. D.Monti, M.F.Saettone, B.Giannaccini, D.Galli-Angeli. (1995). Enhancement of transdermal penetration of dapiprazole through hairless mouse skin. J Control Release 33:71–7
19. R.Pagano, T.E.Thompson (1968). Spherical lipid bilayer membranes: electrical and isotopic studies of ion permeability. J Mol Biol 38:41–57
20. F.Shakeel, S.Baboota, A.Ahuja,. (2008). Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation. Pharmazie 63:580–4
21. B.N.Singh, R.B.Singh, J.Singh (2005). Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 298:98–107
22. H.P.Singh, A.K.Tiwary, S.Jain (2010). Preparation and in vitro, in vivo characterization of elastic liposomes encapsulating cyclodextrin-colchicine complex for topical delivery of colchicine. Yakugaku Zasshi 130:397–407
23. F.Tanaka, T.Fukuse, H.Wada, M.Fukushima. (2000). The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents. Curr Pharm Biotechnol 1:137–64
24. E.Touitou, L.Abed (1985). Effect of propylene glycol, Azone and n-decylmethyl sulfoxide on skin permeation kinetics of 5-fluorouracil. Int J Pharm 27:89–98
25. S.Tsukada, S.Ueda, R.Okada (1984). Preparation of liposome encapsulated antitumor drugs relationship between lipophilicity of and in vitro drug release. Chem Pharm Bull 32:1929–35
26. W.D.Tutrone, R.Saini, S.Caglar,. (2003). Topical therapy for actinic keratoses I: 5-fluorouracil and imiquimod. Cutis 71:365–70
27. P.Utreja, S.Jain, A.K.Tiwar (2011). Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation. Drug Deliv 18:367–76
28. S.Verma, S.K.Singh, P.R.Verma, M.N.Ahsan. (2014). Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box–Behnken design. Drug Dev Ind Pharm 40:1358–70
29. A.C.Williams, B.W.Barry (1991). Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res 8:17–24